Guest guest Posted February 13, 2007 Report Share Posted February 13, 2007 Contact: Vera Hassner Sharav 212-595-8974 veracare@... http://news./s/ap/20070213/ap_on_he_me/rotavirus_vaccine_1 FDA warns of vaccine complications By ANDREW BRIDGES, Associated Press Writer1 hour, 32 minutes ago The government warned doctors and parents Tuesday of reports of potentially life-threatening twisting of the intestines in infants vaccinated against a virus that is the leading cause of early childhood diarrhea. The condition, called intussusception, is the same that led to the withdrawal of the first rotavirus vaccine eight years ago. The Food and Drug Administration said it was unknown whether the recently approved vaccine, called RotaTeq, caused the 28 new cases. The condition also can occur spontaneously. Still, the agency said it was issuing the warning in part to encourage reporting of any additional cases of intestinal twisting or blockage to help it assess any risks associated with the three-shot vaccine series. The vaccine's manufacturer, Merck & Co. Inc., didn't immediately return a call seeking comment. The 28 cases included 16 infants who required intestinal surgery. There have been no reports of deaths. RotaTeq received FDA approval in February 2006. At the time, the FDA and Merck said trials of the vaccine indicated it did not increase the risk of intussusception. But Merck and the Centers for Disease Control and Prevention are conducting follow-up studies of tens of thousands of infants to track any long-term effects of the vaccine. The FDA also is monitoring reports. About 3.5 million doses of the Merck vaccine have been distributed in the U.S., though not all have been used, the FDA said. The earlier rotavirus vaccine, Wyeth's RotaShield, was pulled from the U.S. market in 1999 after it was linked to a small increase in intussusception. In the United States, rotavirus sickens about 2.7 million children younger than 5, sends up to 70,000 to the hospital and causes 20 to 70 deaths each year. ___ On the Net: Food and Drug Administration notification on RotaTeq: http://www.fda.gov/cber/safety/phnrota021307.htm FAIR USE NOTICE: This may contain copyrighted (C ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This material is distributed without profit. Randi J. Airola, © 517-819-5926 http://military-biodefensevaccines.org To receive MBVP E-news: http://military-biodefensevaccines.org click on MBVP Chat List and join. The Chat List provides biodefense information and allows subscribers to interact with one another. This is a public domain. Opinions expressed by individuals are the responsibility of the individual. The MBVP Chat list is a free service of the National Vaccine Information Center (NVIC), which is a non-profit (501C3) educational organization. Donations are tax deductible as provided under law. NVIC does not receive Government subsidies. To support the MBVP of NVIC, go to http://www.nvic.org/makingcashdonations.htm and become a member of NVIC. NVIC publishes a free E-News newsletter with daily analysis and commentary by Co-Founder/President Barbara Loe Fisher on infectious diseases and vaccine research, regulation, policymaking, legislation, and informed consent issues. To receive NVIC E-news: http://www.nvic.org and sign up. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.